News
PROSILICO will attend and present at Biotech Hanse in Stockholm and RSC Anglo-Nordic Medicinal Chemistry…
Urban Fagerholm13 June 2023
PROSILICO attended IDDST in Tokyo 8-10 May and gave an oral presentation of new ANDROMEDA…
Urban Fagerholm22 May 2023
In 49 study comparisons, ANDROMEDA by Prosilico outperformed laboratory methods in 74 % of cases…
Urban Fagerholm21 March 2023
PROSILICO participates in the planned SciLifeLab PULSE cofund postdoctoral programme SciLifeLab has the ambition to…
Urban Fagerholm21 March 2023
Validation of predicted conformal intervals for prediction of human clinical pharmacokinetics https://www.biorxiv.org/content/10.1101/2022.11.10.515917v1
Urban Fagerholm14 November 2022
ANDROMEDA by Prosilico software successfully predicts human clinical pharmacokinetics of 70 drugs out of reach…
Urban Fagerholm10 October 2022
FDA Modernization Act - The bill defines “nonclinical tests or studies ” as a test…
Urban Fagerholm3 October 2022
An Analysis of Laboratory Variability and Thresholds for Human in vitro ADME/PK Methods & Prediction…
Urban Fagerholm3 October 2022